跳至主要内容
临床试验/NCT03760029
NCT03760029已完成不适用

A NATURAL HISTORY STUDY IN CHINESE MALE PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY

Pfizer10 个研究点 分布在 1 个国家目标入组 312 人开始时间: 2019年7月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Pfizer
入组人数
312
试验地点
10
主要终点
Age of Participants When They Failed to Walk

研究概览

简要总结

This is a multicenter, prospective, single cohort study designed to describe the natural history of DMD in Chinese male patients. A total of approximately 330 subjects will be enrolled with the target number of subjects in each group as below:

  • Group 1, Ambulatory subjects aged <6 years, approximately 100 subjects;
  • Group 2, Ambulatory subjects aged >=6 years, approximately 180 subjects;
  • Group 3, Non-ambulatory subjects, approximately 50 subjects. Subjects will visit sites every 6 months. Each subject will be observed for at least 24 months. All subjects will remain enrolled until the study completion date, such that some will have data collected after Month 24. Subjects, who complete Visit 5/Month 24 at least 6 months prior to study completion, will be asked to complete an additional visit at Month 30.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
0 Years 至 —(Child, Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Chinese male patients with any age, diagnosed with DMD. Diagnosis must be confirmed in subject's medical history and by genetic testing obtained during routine clinical care for diagnostic purposes as reported from an appropriate regulated laboratory using a clinically validated genetic test (genetic testing is not provided by the sponsor).
  • Subjects who are >=4 years old must be receiving glucocorticosteroids for a minimum of 6 months prior to signing informed consent. There should be no significant change (<0.2 mg/kg) in dosage or dose regimen (not related to body weight change) for at least 3 months immediately prior to signing the informed consent. Subjects who are aged >4 years will be exempt from this requirement; those not taking GC will be eligible if the initiation of GC treatment in these subjects is considered inappropriate in the opinion of Investigators.

排除标准

  • Any injury which may impact functional testing. Previous injuries must be fully healed prior to consenting. Prior lower limb fractures must be fully healed and at least 3 months from injury date.
  • Presence or history of other musculoskeletal or neurologic disease or somatic disorder not related to DMD including pulmonary, cardiac, and cognitive diseases.
  • Subjects >=4 years old who have not completed the varicella vaccination.
  • Participation in other studies involving investigational drug(s) for a minimum of 90 days prior to signing the informed consent and/or during study participation.

结局指标

主要结局

Age of Participants When They Failed to Walk

时间窗: Up to Month 30

Participant's age at life-altering clinical milestones- failure to walk was calculated based on the birthdate and the date of failure to walk as reported by caregiver during 30 months of this study. Participants who were not reported being failure to walk by their caregivers were censored on the day of their last visit. Kaplan-Meier method was used for analysis.

Age of Participants When They Failed to Stand

时间窗: Up to Month 30

Participant's age at life-altering clinical milestones- failure to stand was calculated based on the birthdate and the date of failure to stand as reported by caregiver during 30 months of this study. Participants who were not reported being failure to stand by their caregivers were censored on the day of their last visit. Kaplan-Meier method was used for analysis.

Age of Participants When They Failed to Self-feed

时间窗: Up to Month 30

Participant's age at life-altering clinical milestones- failure to self-feed during 30 months of this study was analyzed using the Kaplan-Meier method. Age was summarized in years.

Change From Baseline in Northstar Ambulatory Assessment (NSAA) Total Score at Month 6: Ambulatory Participants Aged >=3 Years

时间窗: Baseline (Day 1) and Month 6

NSAA is a 17-item test that grades performance of various functional skills using the following scale: 0 (unable to achieve goal independently), 1 (modified method but achieves goal with no physical assistance), or 2 ("normal"- no obvious modification of activity). The scale assesses activities required to remain functionally ambulant (e.g. rise from the floor), activities that can be difficult even early in the disease (example \[e.g.\] standing on heels) and activities that are known to progressively deteriorate over time (stand from a chair, walk). NSAA total score was calculated by adding the responses of all 17 items and ranged from 0 to 34, with higher scores indicating better function. NSAA was only performed in ambulatory participants aged \>=3 years old as pre-specified in protocol.

Change From Baseline in NSAA Total Score at Month 12: Ambulatory Participants Aged >=3 Years

时间窗: Baseline (Day 1) and Month 12

NSAA is a 17-item test that grades performance of various functional skills using the following scale: 0 (unable to achieve goal independently), 1 (modified method but achieves goal with no physical assistance), or 2 ("normal"- no obvious modification of activity). The scale assesses activities required to remain functionally ambulant (e.g. rise from the floor), activities that can be difficult even early in the disease (e.g. standing on heels) and activities that are known to progressively deteriorate over time (stand from a chair, walk). NSAA total score was calculated by adding the responses of all 17 items and ranged from 0 to 34, with higher scores indicating better function. NSAA was only performed in ambulatory participants aged \>=3 years old as pre-specified in protocol.

Change From Baseline in NSAA Total Score at Month 18: Ambulatory Participants Aged >=3 Years

时间窗: Baseline (Day 1) and Month 18

NSAA is a 17-item test that grades performance of various functional skills using the following scale: 0 (unable to achieve goal independently), 1 (modified method but achieves goal with no physical assistance), or 2 ("normal"- no obvious modification of activity). The scale assesses activities required to remain functionally ambulant (e.g. rise from the floor), activities that can be difficult even early in the disease (e.g. standing on heels) and activities that are known to progressively deteriorate over time (stand from a chair, walk). NSAA total score was calculated by adding the responses of all 17 items and ranged from 0 to 34, with higher scores indicating better function. NSAA was only performed in ambulatory participants aged \>=3 years old as pre-specified in protocol.

Change From Baseline in NSAA Total Score at Month 24: Ambulatory Participants Aged >=3 Years

时间窗: Baseline (Day 1) and Month 24

NSAA is a 17-item test that grades performance of various functional skills using the following scale: 0 (unable to achieve goal independently), 1 (modified method but achieves goal with no physical assistance), or 2 ("normal"- no obvious modification of activity). The scale assesses activities required to remain functionally ambulant (e.g. rise from the floor), activities that can be difficult even early in the disease (e.g. standing on heels) and activities that are known to progressively deteriorate over time (stand from a chair, walk). NSAA total score was calculated by adding the responses of all 17 items and ranged from 0 to 34, with higher scores indicating better function. NSAA was only performed in ambulatory participants aged \>=3 years old as pre-specified in protocol.

Change From Baseline in NSAA Total Score at Month 30: Ambulatory Participants Aged >=3 Years

时间窗: Baseline (Day 1) and Month 30

NSAA is a 17-item test that grades performance of various functional skills using the following scale: 0 (unable to achieve goal independently), 1 (modified method but achieves goal with no physical assistance), or 2 ("normal"- no obvious modification of activity). The scale assesses activities required to remain functionally ambulant (e.g. rise from the floor), activities that can be difficult even early in the disease (e.g. standing on heels) and activities that are known to progressively deteriorate over time (stand from a chair, walk). NSAA total score was calculated by adding the responses of all 17 items and ranged from 0 to 34, with higher scores indicating better function. NSAA was only performed in ambulatory participants aged \>=3 years old as pre-specified in protocol.

Change From Baseline in Performance of Upper Limb (PUL) 2.0 Total Score at Month 6: Participants Aged >=10 Years

时间窗: Baseline (Day 1) and Month 6

PUL 2.0 scale is a 22-item scale used to assess the change that occurs in motor performance of the upper limb overtime from when a participant is still ambulant to the time participant loses all arm function when non-ambulant. PUL 2.0 includes an entry item to define broad starting functional level and 22 items subdivided into shoulder level (six items), mid-level (nine items), and distal level (seven items). Each dimension (shoulder, mid, distal) can be scored separately. There is maximum score of 12 for shoulder level, 17 for mid-level, and 13 for distal level. The total score was calculated by adding three level scores and ranged from 0-42. Higher score indicates better upper limb function. PUL 2.0 total score was assessed in participants aged \>=10 years only as pre-specified in protocol.

Change From Baseline in PUL 2.0 Total Score at Month 12: Participants Aged >=10 Years

时间窗: Baseline (Day 1) and Month 12

PUL 2.0 scale is a 22-item scale used to assess the change that occurs in motor performance of the upper limb overtime from when a participant is still ambulant to the time participant loses all arm function when non-ambulant. PUL 2.0 includes an entry item to define broad starting functional level and 22 items subdivided into shoulder level (six items), mid-level (nine items), and distal level (seven items). Each dimension (shoulder, mid, distal) can be scored separately. There is maximum score of 12 for shoulder level, 17 for mid-level, and 13 for distal level. The total score was calculated by adding three level scores and ranged from 0-42. Higher score indicates better upper limb function. PUL 2.0 total score was assessed in participants aged \>=10 years only as pre-specified in protocol.

Change From Baseline in PUL 2.0 Total Score at Month 18: Participants Aged >=10 Years

时间窗: Baseline (Day 1) and Month 18

PUL 2.0 scale is a 22-item scale used to assess the change that occurs in motor performance of the upper limb overtime from when a participant is still ambulant to the time participant loses all arm function when non-ambulant. PUL 2.0 includes an entry item to define broad starting functional level and 22 items subdivided into shoulder level (six items), mid-level (nine items), and distal level (seven items). Each dimension (shoulder, mid, distal) can be scored separately. There is maximum score of 12 for shoulder level, 17 for mid-level, and 13 for distal level. The total score was calculated by adding three level scores and ranged from 0-42. Higher score indicates better upper limb function. PUL 2.0 total score was assessed in participants aged \>=10 years only as pre-specified in protocol.

Change From Baseline in PUL 2.0 Total Score at Month 24: Participants Aged >=10 Years

时间窗: Baseline (Day 1) and Month 24

PUL 2.0 scale is a 22-item scale used to assess the change that occurs in motor performance of the upper limb overtime from when a participant is still ambulant to the time participant loses all arm function when non-ambulant. PUL 2.0 includes an entry item to define broad starting functional level and 22 items subdivided into shoulder level (six items), mid-level (nine items), and distal level (seven items). Each dimension (shoulder, mid, distal) can be scored separately. There is maximum score of 12 for shoulder level, 17 for mid-level, and 13 for distal level. The total score was calculated by adding three level scores and ranged from 0-42. Higher score indicates better upper limb function. PUL 2.0 total score was assessed in participants aged \>=10 years only as pre-specified in protocol.

Change From Baseline in PUL 2.0 Total Score at Month 30: Participants Aged >=10 Years

时间窗: Baseline (Day 1) and Month 30

PUL 2.0 scale is a 22-item scale used to assess the change that occurs in motor performance of the upper limb overtime from when a participant is still ambulant to the time participant loses all arm function when non-ambulant. PUL 2.0 includes an entry item to define broad starting functional level and 22 items subdivided into shoulder level (six items), mid-level (nine items), and distal level (seven items). Each dimension (shoulder, mid, distal) can be scored separately. There is maximum score of 12 for shoulder level, 17 for mid-level, and 13 for distal level. The total score was calculated by adding three level scores and ranged from 0-42. Higher score indicates better upper limb function. PUL 2.0 total score was assessed in participants aged \>=10 years only as pre-specified in protocol.

Change From Baseline in Rise From Floor Velocity at Month 6: Ambulatory Participants Aged >=3 Years Only

时间窗: Baseline (Day 1) and Month 6

The rise from floor velocity was defined as the reciprocal of the time (in seconds) to rise from floor. The rise from floor test was performed only in ambulatory participants aged \>=3 years old as pre-specified in the protocol.

Change From Baseline in Rise From Floor Velocity at Month 12: Ambulatory Participants Aged >=3 Years Only

时间窗: Baseline (Day 1) and Month 12

The rise from floor velocity was defined as the reciprocal of the time (in seconds) to rise from floor. The rise from floor test was performed only in ambulatory participants aged \>=3 years old as pre-specified in the protocol.

Change From Baseline in Rise From Floor Velocity at Month 18: Ambulatory Participants Aged >=3 Years Only

时间窗: Baseline (Day 1) and Month 18

The rise from floor velocity was defined as the reciprocal of the time (in seconds) to rise from floor. The rise from floor test was performed only in ambulatory participants aged \>=3 years old as pre-specified in the protocol.

Change From Baseline in Rise From Floor Velocity at Month 24: Ambulatory Participants Aged >=3 Years Only

时间窗: Baseline (Day 1) and Month 24

The rise from floor velocity was defined as the reciprocal of the time (in seconds) to rise from floor. The rise from floor test was performed only in ambulatory participants aged \>=3 years old as pre-specified in the protocol.

Change From Baseline in Rise From Floor Velocity at Month 30: Ambulatory Participants Aged >=3 Years Only

时间窗: Baseline (Day 1) and Month 30

The rise from floor velocity was defined as the reciprocal of the time (in seconds) to rise from floor. The rise from floor test was performed only in ambulatory participants aged \>=3 years old as pre-specified in the protocol.

Change From Baseline in 10 Meter Walk or Run Velocity at Month 6: Ambulatory Participants Aged >=3 Years

时间窗: Baseline (Day 1) and Month 6

The 10 meter walk or run test was performed as part of NSAA. The 10 meter walk or run velocity was defined as the reciprocal of the time (in seconds) to complete the 10 meter run or walk test. The 10 meter walk or run test was performed in ambulatory children \>=3 years old only as pre-specified in the protocol.

Change From Baseline in 10 Meter Walk or Run Velocity at Month 12: Ambulatory Participants Aged >=3 Years

时间窗: Baseline (Day 1) and Month 12

The 10 meter walk or run test was performed as part of NSAA. The 10 meter walk or run velocity was defined as the reciprocal of the time (in seconds) to complete the 10 meter run or walk test. The 10 meter walk or run test was performed in ambulatory children \>=3 years old only as pre-specified in the protocol.

Change From Baseline in 10 Meter Walk or Run Velocity at Month 18: Ambulatory Participants Aged >=3 Years

时间窗: Baseline (Day 1) and Month 18

The 10 meter walk or run test was performed as part of NSAA. The 10 meter walk or run velocity was defined as the reciprocal of the time (in seconds) to complete the 10 meter run or walk test. The 10 meter walk or run test was performed in ambulatory children \>=3 years old only as pre-specified in the protocol.

Change From Baseline in 10 Meter Walk or Run Velocity at Month 24: Ambulatory Participants Aged >=3 Years

时间窗: Baseline (Day 1) and Month 24

The 10 meter walk or run test was performed as part of NSAA. The 10 meter walk or run velocity was defined as the reciprocal of the time (in seconds) to complete the 10 meter run or walk test. The 10 meter walk or run test was performed in ambulatory children \>=3 years old only as pre-specified in the protocol.

Change From Baseline in 10 Meter Walk or Run Velocity at Month 30: Ambulatory Participants Aged >=3 Years

时间窗: Baseline (Day 1) and Month 30

The 10 meter walk or run test was performed as part of NSAA. The 10 meter walk or run velocity was defined as the reciprocal of the time (in seconds) to complete the 10 meter run or walk test. The 10 meter walk or run test was performed in ambulatory children \>=3 years old only as pre-specified in the protocol.

Change From Baseline in Knee Extension of Muscle Strength at Month 6: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 6

Muscle strength was recorded by handheld myometry. Left and right knee extension was analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in protocol.

Change From Baseline in Knee Extension of Muscle Strength at Month 12: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 12

Muscle strength was recorded by handheld myometry. Left and right knee extension was analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in protocol.

Change From Baseline in Knee Extension of Muscle Strength at Month 18: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 18

Muscle strength was recorded by handheld myometry. Left and right knee extension was analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in protocol.

Change From Baseline in Knee Extension of Muscle Strength at Month 24: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 24

Muscle strength was recorded by handheld myometry. Left and right knee extension was analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in protocol.

Change From Baseline in Knee Extension of Muscle Strength at Month 30: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 30

Muscle strength was recorded by handheld myometry. Left and right knee extension was analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in protocol.

Change From Baseline in Elbow Flexion of Muscle Strength at Month 6: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 6

Muscle strength was recorded by handheld myometry. Left and right elbow flexion were analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in the protocol.

Change From Baseline in Elbow Flexion of Muscle Strength at Month 12: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 12

Muscle strength was recorded by handheld myometry. Left and right elbow flexion were analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in the protocol.

Change From Baseline in Elbow Flexion of Muscle Strength at Month 18: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 18

Muscle strength was recorded by handheld myometry. Left and right elbow flexion were analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in the protocol.

Change From Baseline in Elbow Flexion of Muscle Strength at Month 24: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 24

Muscle strength was recorded by handheld myometry. Left and right elbow flexion were analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in the protocol.

Change From Baseline in Elbow Flexion of Muscle Strength at Month 30: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 30

Muscle strength was recorded by handheld myometry. Left and right elbow flexion were analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in the protocol.

Change From Baseline in Elbow Extension of Muscle Strength at Month 6: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 6

Muscle strength was recorded by handheld myometry. Left and right elbow extension were analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in protocol.

Change From Baseline in Elbow Extension Muscle Strength at Month 24: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 24

Muscle strength was recorded by handheld myometry. Left and right elbow extension were analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in protocol.

Change From Baseline in Elbow Extension Muscle Strength at Month 12: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 12

Muscle strength was recorded by handheld myometry. Left and right elbow extension were analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in protocol.

Change From Baseline in Elbow Extension Muscle Strength at Month 18: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 18

Muscle strength was recorded by handheld myometry. Left and right elbow extension were analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in protocol.

Change From Baseline in Shoulder Abduction of Muscle Strength at Month 30: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 30

Muscle strength was recorded by handheld myometry. Left and right shoulder abduction were analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in the protocol.

Change From Baseline in Elbow Extension Muscle Strength at Month 30: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 30

Muscle strength was recorded by handheld myometry. Left and right elbow extension were analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in protocol.

Change From Baseline in Shoulder Abduction of Muscle Strength at Month 6: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 6

Muscle strength was recorded by handheld myometry. Left and right shoulder abduction were analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in the protocol.

Change From Baseline in Shoulder Abduction of Muscle Strength at Month 12: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 12

Muscle strength was recorded by handheld myometry. Left and right shoulder abduction were analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in the protocol.

Change From Baseline in Shoulder Abduction of Muscle Strength at Month 18: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 18

Muscle strength was recorded by handheld myometry. Left and right shoulder abduction were analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in the protocol.

Change From Baseline in Shoulder Abduction of Muscle Strength at Month 24: Participants Aged >=5 Years

时间窗: Baseline (Day 1) and Month 24

Muscle strength was recorded by handheld myometry. Left and right shoulder abduction were analyzed. The muscle strength test was only performed in participants \>=5 years old as pre-specified in the protocol.

Change From Baseline in Range of Motion (ROM) at Bilateral Ankles at Month 6

时间窗: Baseline (Day 1) and Month 6

Range of motion was evaluated by using goniometry to record any occurrences of ankle contractures. The ROM at left and right ankles were measured in degrees of passive dorsiflexion.

Change From Baseline in ROM at Bilateral Ankles at Month 12

时间窗: Baseline (Day 1) and Month 12

Range of motion was evaluated by using goniometry to record any occurrences of ankle contractures. The ROM at left and right ankles were measured in degrees of passive dorsiflexion.

Change From Baseline in ROM at Bilateral Ankles at Month 18

时间窗: Baseline (Day 1) and Month 18

Range of motion was evaluated by using goniometry to record any occurrences of ankle contractures. The ROM at left and right ankles were measured in degrees of passive dorsiflexion.

Change From Baseline in ROM at Bilateral Ankles at Month 24

时间窗: Baseline (Day 1) and Month 24

Range of motion was evaluated by using goniometry to record any occurrences of ankle contractures. The ROM at left and right ankles were measured in degrees of passive dorsiflexion.

Change From Baseline in ROM at Bilateral Ankles at Month 30

时间窗: Baseline (Day 1) and Month 30

Range of motion was evaluated by using goniometry to record any occurrences of ankle contractures. The ROM at left and right ankles were measured in degrees of passive dorsiflexion.

Change From Baseline in ROM at Bilateral Elbows at Month 6

时间窗: Baseline (Day 1) and Month 6

Range of motion was evaluated by using goniometry to record any occurrences of elbow contractures. The ROM at left and right elbows were measured in degrees of passive extension.

Change From Baseline in ROM at Bilateral Elbows at Month 12

时间窗: Baseline (Day 1) and Month 12

Range of motion was evaluated by using goniometry to record any occurrences of elbow contractures. The ROM at left and right elbows were measured in degrees of passive extension.

Change From Baseline in ROM at Bilateral Elbows at Month 18

时间窗: Baseline (Day 1) and Month 18

Range of motion was evaluated by using goniometry to record any occurrences of elbow contractures. The ROM at left and right elbows were measured in degrees of passive extension.

Change From Baseline in ROM at Bilateral Elbows at Month 24

时间窗: Baseline (Day 1) and Month 24

Range of motion was evaluated by using goniometry to record any occurrences of elbow contractures. The ROM at left and right elbows were measured in degrees of passive extension.

Change From Baseline in ROM at Bilateral Elbows at Month 30

时间窗: Baseline (Day 1) and Month 30

Range of motion was evaluated by using goniometry to record any occurrences of elbow contractures. The ROM at left and right elbows were measured in degrees of passive extension.

Change From Baseline in Percent Predicted Forced Vital Capacity (%pFVC) at Month 12: Participants Aged >=6 Years

时间窗: Baseline (Day 1) and Month 12

Forced vital capacity (FVC) is the volume of air that can be maximally forcefully exhaled after taking the deepest breath possible and was measured using spirometry. The percent predicted FVC was calculated from FVC (measured in liter) according to age, height (estimated height as derived from the ulna length for non-ambulatory participants), ethnicity, and gender using multi-ethnic reference values for spirometry. The pulmonary function assessments were performed in participants aged \>=6 years as pre-specified in the protocol.

Change From Baseline in %pFVC at Month 24: Participants Aged >=6 Years

时间窗: Baseline (Day 1) and Month 24

FVC is the volume of air that can be maximally forcefully exhaled after taking the deepest breath possible and was measured using spirometry. The percent predicted FVC was calculated from FVC (measured in liter) according to age, height (estimated height as derived from the ulna length for non-ambulatory participants), ethnicity, and gender using multi-ethnic reference values for spirometry. The pulmonary function assessments were performed in participants aged \>=6 years as pre-specified in the protocol.

Change From Baseline in %pFVC at Month 30: Participants Aged >=6 Years

时间窗: Baseline (Day 1) and Month 30

FVC is the volume of air that can be maximally forcefully exhaled after taking the deepest breath possible and was measured using spirometry. The percent predicted FVC was calculated from FVC (measured in liter) according to age, height (estimated height as derived from the ulna length for non-ambulatory participants), ethnicity, and gender using multi-ethnic reference values for spirometry. The pulmonary function assessments were performed in participants aged \>=6 years as pre-specified in the protocol.

Change From Baseline in %pFVC at Month 12: Participants Aged >=6 Years (Unplanned Analysis)

时间窗: Baseline (Day 1) and Month 12

FVC is the volume of air that can be maximally forcefully exhaled after taking the deepest breath possible and was measured using spirometry. The percent predicted FVC was calculated from FVC (measured in liter) according to age, height (estimated height as derived from the ulna length for non-ambulatory participants), ethnicity, and gender using multi-ethnic reference values for spirometry. The pulmonary function assessments were performed in participants aged \>=6 years as pre-specified in the protocol. Incorrect data were addressed by unplanned analysis.

Change From Baseline in %pFVC at Month 24: Participants Aged >=6 Years (Unplanned Analysis)

时间窗: Baseline (Day 1) and Month 24

FVC is the volume of air that can be maximally forcefully exhaled after taking the deepest breath possible and was measured using spirometry. The percent predicted FVC was calculated from FVC (measured in liter) according to age, height (estimated height as derived from the ulna length for non-ambulatory participants), ethnicity, and gender using multi-ethnic reference values for spirometry. The pulmonary function assessments were performed in participants aged \>=6 years as pre-specified in the protocol. Incorrect data were addressed by unplanned analysis.

Change From Baseline in %pFVC at Month 30: Participants Aged >=6 Years (Unplanned Analysis)

时间窗: Baseline (Day 1) and Month 30

FVC is the volume of air that can be maximally forcefully exhaled after taking the deepest breath possible and was measured using spirometry. The percent predicted FVC was calculated from FVC (measured in liter) according to age, height (estimated height as derived from the ulna length for non-ambulatory participants), ethnicity, and gender using multi-ethnic reference values for spirometry. The pulmonary function assessments were performed in participants aged \>=6 years as pre-specified in the protocol. Incorrect data were addressed by unplanned analysis.

Change From Baseline in Percent Predicted Forced Expiratory Volume in One Second (%pFEV1) at Month 12: Participants Aged >=6 Years

时间窗: Baseline (Day 1) and Month 12

Forced expiratory volume in one second (FEV1) is the volume of air forcefully exhaled in 1 second and was measured using spirometry. The %pFEV1 was calculated from FEV1 (measured in liter) according to age, height (estimated height as derived from the ulna length for non-ambulatory participants), ethnicity, and gender using multi-ethnic reference values for Spirometry. The pulmonary function assessments were performed only in participants \>=6 years old as pre-specified in protocol.

Change From Baseline in %pFEV1 at Month 24: Participants Aged >=6 Years

时间窗: Baseline (Day 1) and Month 24

FEV1 is the volume of air forcefully exhaled in 1 second and was measured using spirometry. The %pFEV1 was calculated from FEV1 (measured in liter) according to age, height (estimated height as derived from the ulna length for non-ambulatory participants), ethnicity, and gender using multi-ethnic reference values for Spirometry. The pulmonary function assessments were performed only in participants \>=6 years old as pre-specified in protocol.

Change From Baseline in %pFEV1 at Month 30: Participants Aged >=6 Years

时间窗: Baseline (Day 1) and Month 30

FEV1 is the volume of air forcefully exhaled in 1 second and was measured using spirometry. The %pFEV1 was calculated from FEV1 (measured in liter) according to age, height (estimated height as derived from the ulna length for non-ambulatory participants), ethnicity, and gender using multi-ethnic reference values for Spirometry. The pulmonary function assessments were performed only in participants \>=6 years old as pre-specified in protocol.

Change From Baseline in %pFEV1 at Month 12: Participants Aged >=6 Years (Unplanned Analysis)

时间窗: Baseline (Day 1) and Month 12

FEV1 is the volume of air forcefully exhaled in 1 second and was measured using spirometry. The %pFEV1 was calculated from FEV1 (measured in liter) according to age, height (estimated height as derived from the ulna length for non-ambulatory participants), ethnicity, and gender using multi-ethnic reference values for Spirometry. The pulmonary function assessments were performed only in participants \>=6 years old as pre-specified in protocol. Incorrect data were addressed by unplanned analysis.

Change From Baseline in %pFEV1 at Month 24: Participants Aged >=6 Years (Unplanned Analysis)

时间窗: Baseline (Day 1) and Month 24

FEV1 is the volume of air forcefully exhaled in 1 second and was measured using spirometry. The %pFEV1 was calculated from FEV1 (measured in liter) according to age, height (estimated height as derived from the ulna length for non-ambulatory participants), ethnicity, and gender using multi-ethnic reference values for Spirometry. The pulmonary function assessments were performed only in participants \>=6 years old as pre-specified in protocol. Incorrect data were addressed by unplanned analysis.

Change From Baseline in %pFEV1 at Month 30: Participants Aged >=6 Years (Unplanned Analysis)

时间窗: Baseline (Day 1) and Month 30

FEV1 is the volume of air forcefully exhaled in 1 second and was measured using spirometry. The %pFEV1 was calculated from FEV1 (measured in liter) according to age, height (estimated height as derived from the ulna length for non-ambulatory participants), ethnicity, and gender using multi-ethnic reference values for Spirometry. The pulmonary function assessments were performed only in participants \>=6 years old as pre-specified in protocol. Incorrect data were addressed by unplanned analysis.

Change From Baseline in Maximum Inspiratory Pressure at Month 12: Participants Aged >=6 Years

时间窗: Baseline (Day 1) and Month 12

The pulmonary function assessments were performed only in participants \>=6 years old as pre-specified in protocol.

Change From Baseline in Maximum Inspiratory Pressure at Month 24: Participants Aged >=6 Years

时间窗: Baseline (Day 1) and Month 24

The pulmonary function assessments were performed only in participants \>=6 years old as pre-specified in protocol.

Change From Baseline in Maximum Inspiratory Pressure at Month 30: Participants Aged >=6 Years

时间窗: Baseline (Day 1) and Month 30

The pulmonary function assessments were performed only in participants \>=6 years old as pre-specified in protocol.

Change From Baseline in Maximum Expiratory Pressure at Month 12: Participants Aged >=6 Years

时间窗: Baseline (Day 1) and Month 12

The pulmonary function assessments were performed only in participants \>=6 years old as pre-specified in SAP.

Change From Baseline in Maximum Expiratory Pressure at Month 24: Participants Aged >=6 Years

时间窗: Baseline (Day 1) and Month 24

The pulmonary function assessments were performed only in participants \>=6 years old as pre-specified in SAP.

Change From Baseline in Maximum Expiratory Pressure at Month 30: Participants Aged >=6 Years

时间窗: Baseline (Day 1) and Month 30

The pulmonary function assessments were performed only in participants \>=6 years old as pre-specified in SAP.

Change From Baseline in Peak Cough Flow at Month 12: Participants Aged >=6 Years

时间窗: Baseline (Day 1) and Month 12

The pulmonary function assessments were performed only in participants \>=6 years old as pre-specified in protocol.

Change From Baseline in Peak Cough Flow at Month 24: Participants Aged >=6 Years

时间窗: Baseline (Day 1) and Month 24

The pulmonary function assessments were performed only in participants \>=6 years old as pre-specified in protocol.

Change From Baseline in Peak Cough Flow at Month 30: Participants Aged >=6 Years

时间窗: Baseline (Day 1) and Month 30

The pulmonary function assessments were performed only in participants \>=6 years old as pre-specified in protocol.

Change From Baseline in Peak Cough Flow at Month 12: Participants Aged >=6 Years (Unplanned Analysis)

时间窗: Baseline (Day 1) and Month 12

The pulmonary function assessments were performed only in participants \>=6 years old as pre-specified in protocol. Incorrect data were addressed by unplanned analysis.

Change From Baseline in Peak Cough Flow at Month 24: Participants Aged >=6 Years (Unplanned Analysis)

时间窗: Baseline (Day 1) and Month 24

The pulmonary function assessments were performed only in participants \>=6 years old as pre-specified in protocol. Incorrect data were addressed by unplanned analysis.

Change From Baseline in Peak Cough Flow at Month 30: Participants Aged >=6 Years (Unplanned Analysis)

时间窗: Baseline (Day 1) and Month 30

The pulmonary function assessments were performed only in participants \>=6 years old as pre-specified in protocol. Incorrect data were addressed by unplanned analysis.

Change From Baseline in Left Ventricular Ejection Fraction (LVEF) at Month 12: Participants Aged >=6 Years

时间窗: Baseline (Day 1) and Month 12

LVEF was the percentage of blood that was ejected out of left ventricle with each contraction, estimated by echocardiography. The LVEF was only performed in participants \>=6 years old as pre-specified in protocol.

Change From Baseline in LVEF at Month 24: Participants Aged >=6 Years

时间窗: Baseline (Day 1) and Month 24

LVEF was the percentage of blood that was ejected out of left ventricle with each contraction, estimated by echocardiography. The LVEF was only performed in participants \>=6 years old as pre-specified in protocol.

Change From Baseline in LVEF at Month 30: Participants Aged >=6 Years

时间窗: Baseline (Day 1) and Month 30

LVEF was the percentage of blood that was ejected out of left ventricle with each contraction, estimated by echocardiography. The LVEF was only performed in participants \>=6 years old as pre-specified in protocol.

Change From Baseline in LVEF at Month 12: Participants Aged >=6 Years (Unplanned Analysis)

时间窗: Baseline (Day 1) and Month 12

LVEF was the percentage of blood that was ejected out of left ventricle with each contraction, estimated by echocardiography. The LVEF was only performed in participants \>=6 years old as pre-specified in protocol. Incorrect data were addressed by unplanned analysis.

Change From Baseline in LVEF at Month 24: Participants Aged >=6 Years (Unplanned Analysis)

时间窗: Baseline (Day 1) and Month 24

LVEF was the percentage of blood that was ejected out of left ventricle with each contraction, estimated by echocardiography. The LVEF was only performed in participants \>=6 years old as pre-specified in protocol. Incorrect data were addressed by unplanned analysis.

Change From Baseline in LVEF at Month 30: Participants Aged >=6 Years (Unplanned Analysis)

时间窗: Baseline (Day 1) and Month 30

LVEF was the percentage of blood that was ejected out of left ventricle with each contraction, estimated by echocardiography. The LVEF was only performed in participants \>=6 years old as pre-specified in protocol. Incorrect data were addressed by unplanned analysis.

Change From Baseline in Wechsler Intelligence Scale for Children (WISC)-IV Score at Month 24: Ambulatory Participants >= 6 to <=16 Years

时间窗: Baseline (Day 1) and Month 24

WISC-IV is an individually administered intelligence test for children between the ages of 6 and 16. The WISC-IV Composites are: Verbal Comprehension, Perceptual Reasoning, Working Memory, and Processing Speed. Scores from the Composites constitute the WISC-IV Full Scale IQ score which ranges from 40 (Exceptionally Low) to 160 (Exceptionally Superior), higher scores indicated more intelligence. The WISC was only performed in ambulatory participants \>= 6 to \<=16 years old as pre-specified in the protocol.

次要结局

  • Number of Participants With Type of DMD Mutation(Up to Month 30)
  • Number of Participants With Each Affected Exon by Mutation Types(Up to Month 30)
  • Number of Participants With DMD Mutations Affecting Any Exon Between Exon 9 and Exon 13 or Deletion That Affects Both Exon 29 and Exon 30(Up to Month 30)
  • Change From Baseline in Pediatric Outcomes Data Collection Instrument (PODCI) Global Functioning Scale and Each Core Scale Score (Pediatric Parent Report) at Months 6, 12, 18, 24 and 30(Baseline (Day 1) and Months 6, 12, 18, 24 and 30)
  • Change From Baseline in PODCI Global Functioning Scale and Each Core Scale Score (Adolescent Parent Report) at Months 6, 12, 18, 24 and 30(Baseline (Day 1) and Months 6, 12, 18, 24 and 30)
  • Change From Baseline in PODCI Global Functioning Scale and Each Core Scale Score (Adolescent Self Report) at Months 6, 12, 18, 24 and 30(Baseline (Day 1) and Months 6, 12, 18, 24 and 30)
  • Number of Participants According to Response to Each European Quality of Life (EuroQoL) 5 Dimension 3 Level (EQ-5D-3L) 5 Dimensions at Month 12(Months 12)
  • Number of Participants According to Response to Each EQ-5D-3L 5 Dimensions at Month 24(Month 24)
  • Number of Participants According to Response to Each EQ-5D-3L 5 Dimensions at Month 30(Month 30)
  • Change From Baseline in EQ-5D-3L Visual Analogue Score (VAS) Assessment at Months 12, 24 and 30(Baseline (Day 1) and Months 12, 24 and 30)
  • Change From Baseline in EQ-5D-3L Index Score at Months 12, 24 and 30(Baseline (Day 1) and Months 12, 24, and 30)
  • Number of Participants According to Response to Each EuroQoL 5 Dimension Youth (EQ-5D-Y) 5 Dimensions at Month 12(Month 12)
  • Number of Participants According to Response to Each EQ-5D-Y 5 Dimensions at Month 24(Month 24)
  • Number of Participants According to Response to EQ-5D-Y 5 Dimensions at Month 30(Month 30)
  • Change From Baseline in EQ-5D-Y VAS Assessment at Months 12, 24, and 30(Baseline (Day 1) and Months 12, 24, and 30)
  • Change From Baseline in EQ-5D-Y Index Score at Months 12, 24, and 30(Baseline (Day 1) and Months 12, 24, and 30)
  • Change From Baseline in Healthcare Resource Utilization (HRU) Survey Responses: Visit to Primary Care Physician, Emergency Room and Office Visits at Months 12, 24, and 30(Baseline (Day 1) and Months 12, 24, and 30)
  • Change From Baseline in HRU Survey Responses: Number of Nights in Hospital Due to Disease/Medication for Disease at Months 12, 24, and 30(Baseline (Day 1) and Months 12, 24, and 30)
  • Change From Baseline in Out-of-Pocket Money of HRU Survey at Months 12, 24 and 30(Baseline (Day 1) and Months 12, 24, and 30)
  • Change From Baseline in Percent Activity Impairment as Per Work Productivity and Activity Impairment Questionnaire Adapted for Caregiving (WPAI:CG) Caregiver Unchanged at Months 12, 24, and 30(Baseline (Day 1) and Months 12, 24, and 30)
  • Change From Baseline in Percent Work Time Missed as Per WPAI: CG Caregiver Unchanged at Month 12(Baseline (Day 1) and Month 12)
  • Change From Baseline in Percent Work Time Missed as Per WPAI: CG Caregiver Unchanged at Month 24(Baseline (Day 1) and Month 24)
  • Change From Baseline in Percent Work Time Missed as Per WPAI: CG Caregiver Unchanged at Month 30(Baseline (Day 1) and Month 30)
  • Change From Baseline in Percent Overall Work Impairment WPAI: CG Caregiver Unchanged at Months 12, 24, and 30(Baseline (Day 1) and Months 12, 24, and 30)
  • Percent Activity Impairment Score as Per WPAI: CG at Months 12, 24, and 30(Months 12, 24, and 30)
  • Percent Work Time Missed Score as Per WPAI: CG at Month 12(Month 12)
  • Percent Work Time Missed Score as Per WPAI: CG at Month 24(Month 24)
  • Percent Work Time Missed Score as Per WPAI: CG at Month 30(Month 30)
  • Percent Overall Work Impairment Scores as Per WPAI: CG at Months 12, 24, and 30(Months 12, 24, and 30)

研究者

发起方
Pfizer
申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验